| Literature DB >> 31009935 |
Giovanni Fiorito1,2, Cathal McCrory3,2, Oliver Robinson4,2, Cristian Carmeli5,2, Carolina Ochoa-Rosales6,7,2, Yan Zhang8,2, Elena Colicino9,2, Pierre-Antoine Dugué10,11,12,2, Fanny Artaud13,2, Gareth J McKay14,2, Ayoung Jeong15,16,2, Pashupati P Mishra17,2, Therese H Nøst18,19,2, Vittorio Krogh20, Salvatore Panico21, Carlotta Sacerdote22, Rosario Tumino23, Domenico Palli24, Giuseppe Matullo1,25, Simonetta Guarrera1,25, Martina Gandini26, Murielle Bochud5, Emmanouil Dermitzakis5, Taulant Muka6,27, Joel Schwartz28, Pantel S Vokonas29, Allan Just9, Allison M Hodge10,11, Graham G Giles10,11,12, Melissa C Southey10,12,30, Mikko A Hurme31, Ian Young14, Amy Jayne McKnight14, Sonja Kunze32,33, Melanie Waldenberger32,33,34, Annette Peters32,33,34,35, Lars Schwettmann36,37,38, Eiliv Lund18,38, Andrea Baccarelli39,38, Roger L Milne10,11,12,38, Rose A Kenny3,38, Alexis Elbaz13,38, Hermann Brenner8,40,38, Frank Kee14,38, Trudy Voortman6,38, Nicole Probst-Hensch15,16,38, Terho Lehtimäki17,38, Paul Elliot4,38, Silvia Stringhini5,41,38, Paolo Vineis4,38, Silvia Polidoro1,38.
Abstract
Differences in health status by socioeconomic position (SEP) tend to be more evident at older ages, suggesting the involvement of a biological mechanism responsive to the accumulation of deleterious exposures across the lifespan. DNA methylation (DNAm) has been proposed as a biomarker of biological aging that conserves memory of endogenous and exogenous stress during life.We examined the association of education level, as an indicator of SEP, and lifestyle-related variables with four biomarkers of age-dependent DNAm dysregulation: the total number of stochastic epigenetic mutations (SEMs) and three epigenetic clocks (Horvath, Hannum and Levine), in 18 cohorts spanning 12 countries.The four biological aging biomarkers were associated with education and different sets of risk factors independently, and the magnitude of the effects differed depending on the biomarker and the predictor. On average, the effect of low education on epigenetic aging was comparable with those of other lifestyle-related risk factors (obesity, alcohol intake), with the exception of smoking, which had a significantly stronger effect.Our study shows that low education is an independent predictor of accelerated biological (epigenetic) aging and that epigenetic clocks appear to be good candidates for disentangling the biological pathways underlying social inequalities in healthy aging and longevity.Entities:
Keywords: biological aging; education; epigenetic clocks; socioeconomic position
Mesh:
Year: 2019 PMID: 31009935 PMCID: PMC6503871 DOI: 10.18632/aging.101900
Source DB: PubMed Journal: Aging (Albany NY) ISSN: 1945-4589 Impact factor: 5.682
Study sample descriptive statistics.
| AIRWAVE | The Airwave Health Monitoring Study | UK | Illumina EPIC chip (850K) | 1,127 | 41 (13 - 65) | 458 (41%) | [ |
| EXPOsOMICS 'EPIC CVD' | The European Prospective Investigation into Cancer and Nutrition - EXPOsOMICS subsample | Italy | Illumina 450K BeadChip | 313 | 57 (35 - 75) | 167 (53%) | [ |
| EPIC | The European Prospective Investigation into Cancer and Nutrition | Italy | Illumina 450K BeadChip | 1,803 | 53 (35 - 75) | 1,114 (62%) | [ |
| ESTHER 1 | Epidemiological investigations on chances of preventing, recognizing early and optimally treating chronic diseases in an elderly population | Germany | Illumina 450K BeadChip | 1,000 | 62 (48 - 75) | 500 (50%) | [ |
| ESTHER 2 | Epidemiological investigations on chances of preventing, recognizing early and optimally treating chronic diseases in an elderly population | Germany | Illumina EPIC chip (850K) | 864 | 63 (48 - 75) | 390 (45%) | [ |
| KORA | Cooperative Health Research in the Region of Augsburg (KORA-F4) | Germany | Illumina 450K BeadChip | 1,727 | 61 (32 - 81) | 882 (51%) | [ |
| MCCS | Melbourne Collaborative Cohort Study | Australia | Illumina 450K BeadChip | 2,817 | 59 (40 - 70) | 1,095 (39%) | [ |
| NAS | Normative aging study | USA | Illumina 450K BeadChip | 624 | 72 (55 - 91) | 0 (0%) | [ |
| NOWAC | The Norwegian Women and Cancer Study | Norway | Illumina 450K BeadChip | 632 | 56 (47 - 63) | 632 (100%) | |
| NICOLA | Northern Ireland Cohort Longitudinal Study of Ageing | Northern Ireland | Illumina EPIC chip (850K) | 1,929 | 64 (40 - 96) | 988 (51%) | [ |
| RS-Bios | Rotterdam Study 1,2 | Netherlands | Illumina 450K BeadChip | 720 | 68 (52 - 80) | 304 (42%) | [ |
| RSIII-1 | Rotterdam Study 3 | Netherlands | Illumina 450K BeadChip | 730 | 60 (46 - 89) | 335 (46%) | [ |
| SAPALDIA | Swiss Study on Air Pollution and Lung Diseases in Adults | Switzerland | Illumina 450K BeadChip | 402 | 57 (38 - 81) | 184 (46%) | [REMOVED HYPERLINK FIELD] [ |
| SKIPOGH a | Swiss Kidney Project on Genes in Hypertension | Switzerland | Illumina 450K BeadChip | 250 | 51 (26 - 82) | 132 (53%) | [ |
| SKIPOGH b | Swiss Kidney Project on Genes in Hypertension | Switzerland | Illumina EPIC chip (850K) | 451 | 54 (25 - 89) | 231 (51%) | [ |
| TERRE | Case-control study of Parkinson’s disease in French farmers (only controls were used) | France | Illumina EPIC chip (850K) | 174 | 67 (41 - 76) | 80 (46%) | [ |
| TILDA | The Irish Longitudinal Study on aging | Ireland | Illumina EPIC chip (850K) | 490 | 62 (50 - 80) | 246 (50%) | [ |
| YFS | Young Finns Study | Finland | Illumina 450K BeadChip | 186 | 44 (34 - 49) | 72 (39%) | [ |
Results of linear regressions using epigenetic aging biomarkers as outcomes and lifestyle related risk factors as predictors.
| Medium | 0.17 (-0.07; 0.42) | 0.11 (-0.07; 0.28) | 0.11 (-0.08; 0.29) | ||
| Low | |||||
| Former | 0.13 (-0.04; 0.29) | 0.11 (-0.05; 0.26) | |||
| Current | -0.06 (-0.24; 0.13) | -0.08 (-0.27; 0.12) | |||
| BMI < 30 | -0.01 (-0.18; 0.16) | -0.01 (-0.18; 0.15) | |||
| BMI ≥ 30 | -0.06 (-0.26; 0.15) | -0.07 (-0.27; 0.14) | |||
| Occasional | -0.12 (-0.31; 0.08) | -0.10 (-0.29; 0.08) | -0.02 (-0.19; 0.15) | 0.00 (-0.18; 0.18) | |
| Habitual | 0.22 (-0.05; 0.49) | 0.15 (-0.11; 0.4) | 0.19 (-0.07; 0.44) | ||
| Medium | 0.00 (-0.21; 0.21) | -0.03 (-0.21; 0.15) | 0.05 (-0.11; 0.21) | 0.08 (-0.09; 0.24) | |
| Low | 0.03 (-0.28; 0.35) | -0.03 (-0.32; 0.26) | |||
| Medium | |||||
| Low | |||||
| Former | 0.04 (-0.08; 0.16) | 0.01 (-0.12; 0.13) | |||
| Current | |||||
| BMI < 30 | |||||
| BMI ≥ 30 | |||||
| Occasional | -0.05 (-0.19; 0.09) | 0.03 (-0.11; 0.17) | -0.08 (-0.36; 0.20) | 0.10 (-0.14; 0.34) | |
| Habitual | 0.14 (-0.03; 0.31) | ||||
| Medium | 0.07 (-0.08; 0.22) | 0.07 (-0.07; 0.20) | 0.16 (-0.17; 0.49) | 0.20 (-0.04; 0.44) | |
| Low | 0.08 (-0.15; 0.32) | 0.05 (-0.20; 0.30) | 0.42 (-0.12; 0.96) | 0.31 (-0.13; 0.74) | |
*** p < 0.001; ** p < 0.01; * p < 0.05; + p < 0.10
Model 1 includes age, sex, and cohort specific covariates; Model 2 includes additional adjustment for education, smoking, BMI, alcohol and physical activity.
Figure 1Effect sizes (interpretable as years of increasing/decreasing epigenetic age) of the association between different risk factors and four epigenetic aging biomarkers: total number of stochastic epigenetic mutations (SEMs, red), Horvath epigenetic age acceleration (orange), Hannum epigenetic age acceleration (green) and Levine epigenetic age acceleration next-generation clock (blue).